Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.83% |
| 2 | Financials | 7.37% |
| 3 | Consumer Discretionary | 6.6% |
| 4 | Communication Services | 5.05% |
| 5 | Healthcare | 4.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3551
Eton Pharmaceutcials
ETON
$1.12B
| $653K | ﹤0.01% |
45,790
+1,129
| +3% | +$17.8K |
|
3552
International Money Express
IMXI
$353M
| $650K | ﹤0.01% |
64,468
+9,627
| +18% | +$110K |
|
3553
Mayville Engineering Co
MEC
$597M
| $646K | ﹤0.01% |
40,502
+10,865
| +37% | +$155K |
|
3554
Simulations Plus
SLP
$370M
| $646K | ﹤0.01% |
37,008
+15,393
| +71% | +$432K |
|
3555
Velocity Financial
VEL
$715M
| $642K | ﹤0.01% |
34,616
+19,480
| +129% | +$341K |
|
|
NESR
3556
National Energy Services Reunited Corp
NESR
$3.62B
| $640K | ﹤0.01% |
106,234
+69,324
| +188% | +$430K |
|
|
KRMN
3557
Karman Holdings
KRMN
$8.02B
| $639K | ﹤0.01% |
+12,691
| New | +$511K |
|
3558
Aehr Test Systems
AEHR
$4.02B
| $638K | ﹤0.01% |
49,343
+18,536
| +60% | +$176K |
|
3559
Urban One Class D
UONEK
$24.1M
| $637K | ﹤0.01% |
100,020
+14,896
| +17% | +$89.1K |
|
3560
Anterix
ATEX
$1.79B
| $636K | ﹤0.01% |
24,812
-8,309
| -25% | -$243K |
|
3561
Critical Metals Corp
CRML
$967M
| $636K | ﹤0.01% |
177,673
+146,936
| +478% | +$268K |
|
3562
Brady Corp
BRC
$4.43B
| $636K | ﹤0.01% |
9,357
-5,787
| -38% | -$403K |
|
3563
Intrepid Potash
IPI
$484M
| $636K | ﹤0.01% |
17,799
+6,791
| +62% | +$232K |
|
3564
Movado Group
MOV
$796M
| $636K | ﹤0.01% |
41,675
+24,874
| +148% | +$380K |
|
3565
Jack in the Box
JACK
$358M
| $634K | ﹤0.01% |
36,321
+7,926
| +28% | +$178K |
|
|
PHLT
3566
DELISTED
Performant Healthcare Inc
PHLT
| $634K | ﹤0.01% |
158,511
+69,046
| +77% | +$196K |
|
3567
Riley Exploration Permian
REPX
$786M
| $634K | ﹤0.01% |
24,170
+10,625
| +78% | +$281K |
|
3568
NVE Corp
NVEC
$563M
| $630K | ﹤0.01% |
8,562
+3,356
| +64% | +$222K |
|
|
ATXS
3569
DELISTED
Astria Therapeutics
ATXS
| $630K | ﹤0.01% |
117,534
+44,901
| +62% | +$218K |
|
3570
Fidelity D&D Bancorp
FDBC
$321M
| $630K | ﹤0.01% |
13,685
+4,234
| +45% | +$174K |
|
3571
CALL
Norwegian Cruise Line
NCLH
$8.98B
| $629K | ﹤0.01% |
31,000
-307,400
| -91% | -$5.5M |
|
3572
Compass Therapeutics
CMPX
$407M
| $628K | ﹤0.01% |
241,721
+122,990
| +104% | +$254K |
|
3573
Vaalco Energy
EGY
$592M
| $626K | ﹤0.01% |
173,486
+44,927
| +35% | +$156K |
|
|
CTEV
3574
Claritev Corp
CTEV
$716M
| $625K | ﹤0.01% |
+13,849
| New | +$398K |
|
3575
Greenlight Captial
GLRE
$512M
| $625K | ﹤0.01% |
43,476
+16,211
| +59% | +$223K |
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays deployed $35.4B of net new capital in Q2 2025, opening 461 new positions and adding to 2,914 existing holdings. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.54B trimmed.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.